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Abstract
Background: Appropriate case management of suspected malaria in Cambodia is critical given anti-malarial drug
resistance in the region. Improving diagnosis and the use of recommended malarial treatments is a challenge in
Cambodia where self-treatment and usage of drug cocktails is widespread, a notable difference from malaria
treatment seeking in other countries. This qualitative study adds to the limited evidence base on Cambodian
practices, aiming to understand the demand-side factors influencing treatment-seeking behaviour, including the
types of home treatments, perceptions of cocktail medicines and reasons for diagnostic testing. The findings may
help guide intervention design.
Methods: The study used in-depth interviews (IDIs) (N = 16) and focus group discussions (FGDs) (N = 12) with
Cambodian adults from malaria-endemic areas who had experienced malaria fever in the previous two weeks. Data
were analysed using NVivo software.
Results: Findings suggest that Cambodians initially treat suspected malaria at home with home remedies and
traditional medicines. When seeking treatment outside the home, respondents frequently reported receiving a
cocktail of medicines from trusted providers. Cocktails are perceived as less expensive and more effective than
full-course, pre-packaged medicines. Barriers to diagnostic testing include a belief in the ability to self-diagnose
based on symptoms, cost and reliance on providers to recommend a test. Factors that facilitate testing include
recommendation by trusted providers and a belief that anti-malarial treatment for illnesses other than malaria
can be harmful.
Conclusions: Treatment-seeking behaviour for malaria in Cambodia is complex, driven by cultural norms,
practicalities and episode-related factors. Effective malaria treatment programmes will benefit from interventions
and communication materials that leverage these demand-side factors, promoting prompt visits to facilities for
suspected malaria and challenging patients’ misconceptions about the effectiveness of cocktails. Given the
importance of the patient-provider interaction and the pivotal role that providers play in ensuring the delivery of
appropriate malaria care, future research and interventions should also focus on the supply side factors influencing
provider behaviour.
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Background
In Cambodia, an estimated 2.65 million people are at
risk of malaria [1]. The Cambodian Ministry of Health
estimates that 83,777 outpatient and 4,045 inpatient
malaria cases were reported in 2009, with this disease
accounting for 0.6% of all outpatient cases and 3.5% of
all inpatient cases in the same year [2]. Estimated preva-
lence rates range from 3.0% to 12.3% in malaria-prone
provinces, with the epidemiology of malaria varying
widely across the country. Prevalence is highest around
the tropical forests located on the country borders, cov-
ering 60% of Cambodia’s landmass. Parasite prevalence
rates vary and are reported to reach 15% to 40% in re-
mote, forested areas, with much lower rates in the plains
[3]. In the northeast, malaria transmission is relatively
high; the reported annual incidence rate lies between 11
to 50 cases per 1,000 habitants and Plasmodium falcip-
arum, the deadliest strain of malaria, predominates [4].
By contrast, along the western border with Thailand, P.
falciparum malaria transmission is generally lower than
the northeast and Plasmodium vivax predominates [5,6].
Malaria transmission risk in Cambodia is associated with
the rainy season, typically peaking in August and Sep-
tember. Unlike many areas of sub-Saharan Africa, the
highest burden of malaria infection afflicts adults who
work and stay overnight in the forests.
The border between Cambodia and Thailand serves as
an epicentre of multidrug resistance [5,7]. Since the 1970s,
this area has been the hotspot for the development of
anti-malarial resistant parasites; resistance to anti-malar-
ials, including chloroquine and sulphadoxine-pyrimeth-
amine, subsequently spread to other parts of Asia and
Africa [8]. In 2009, artemisinin-resistant P. falciparum
malaria was confirmed in Cambodia’s Pailin province [9].
Experts believe a number of factors have contributed to
the emergence of drug resistance in Cambodia: 1) previ-
ously unregulated sales of artemisinin monotherapy; 2)
limited access to artemisinin combination therapy (ACT);
3) ACT that are not co-formulated (facilitating continued
use of artemisinin monotherapy); and 4) ubiquitous coun-
terfeit and substandard medicines [9].
Over the past 10 years, the Cambodia National Mal-
aria (CNM) programme has pioneered a number of in-
novative malaria control approaches, many of which
have become accepted as standard practice in malaria-
endemic nations. For example, since 2000, CNM has
recommended using ACT (artesunate and mefloquine)
as the first-line treatment for P. falciparum malaria and
chloroquine as the first-line treatment for P. vivax mal-
aria. Before treatment, the National Treatment Guide-
lines instruct providers to confirm malaria infection
through microscopy or a rapid diagnostic test (RDT). In
2008, CNM changed the protocol for treating malaria in
districts with confirmed multidrug resistance, switching
to dihydroartemisinin + piperaquine (DHA + PPQ), a
fixed-dose combination, as the first-line treatment.
Under the Resistance Containment Programme, CNM
launched multiple initiatives including a ban on the sale
of artemisinin monotherapy [10] as well as community
level services to facilitate rapid diagnosis and treatment
with the correct first-line anti-malarials [11]. Other na-
tional malaria control efforts include the provision of
highly subsidized RDTs and ACT treatments in the pri-
vate sector since 2003, the provision of these commod-
ities for free in the public health sector [12,13], and
regular monitoring of the quality of anti-malarials in
both the public and private health sectors at sentinel
sites [14].
Despite these efforts, recent research in Cambodia
shows that rates of diagnostic testing and prescription of
first-line treatment for confirmed cases remains rela-
tively low among persons with malaria fever. Supply side
data from outlet surveys show that the availability of
diagnostic tests and the first-line treatment is variable,
with higher availability in the public sector, but lower
stocking rates in the private sector [15]. As such, when
patients seek out treatment for malaria fever, the diag-
nostic tests and/or the first-line treatment may not be
available. In addition, other supply side research has
shown that many of the anti-malarials may be sub-
standard or fake in Cambodia [14]. Moreover, providers
may prescribe unsuitable dosages, incorrect medicines
and improper duration of treatment [16]. In addition,
household survey data suggest that many people with
malaria fever rely on home remedies, such as sponge
baths and traditional medicines made from a variety of
herbal or plant sources, which they self-administer
[17,18]. This reliance on self-treatment with home rem-
edies may delay patients from seeking proper care. In
addition, while nearly half of all Cambodians who seek
care for malaria symptoms receive a blood test, patients
most commonly received medicines sold or dispensed by
health providers as “drug cocktails” when treating these
fevers [18], a finding supported by other quantitative re-
search [11,19]. Cocktails typically consist of a small plas-
tic bag containing one or more tablets of various
medicines including antipyretics, vitamins, anti-malar-
ials, antihistamines and antibiotics [11].
The widespread use of cocktails creates challenges and
dangers for combating malaria in Cambodia. First, as it
is the provider who decides on the composition of the
cocktail, it is unclear what patients receive in their plas-
tic bags and whether they even receive an anti-malarial.
If an anti-malarial is provided, it may be an incomplete
dose or an oral artemisinin monotherapy – both of
which lead to parasite drug resistance [20]. The variation
in the number of cocktail packets bought from the pro-
vider adds another threat to combating drug resistance.
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Even though providers often present multiple packets or
pills as a full course of treatment, some patients do not
always choose to purchase a full course; factors such as
affordability and illness severity sometimes limit the
number of cocktail packets that patients buy [11]. For
these reasons, Cambodian national malaria control
efforts have also focused on increasing consumer aware-
ness of the dangers of cocktail medicines through behav-
iour change communication (BCC) campaigns.
Efforts to change how Cambodians approach malaria
treatment face notable challenges. In general, treatment-
seeking behaviour for illness is a highly complex process.
Around the globe, people frequently seek multiple sources
of treatment and many self-medicate or undergo some
type of treatment at home, outside of a medical facility.
People also often have specific perceptions of medicines,
believing that some are more effective than others. More-
over, specific cultural beliefs, norms and attitudes are likely
to influence the treatment-seeking process [21-24]. Nu-
merous research studies, primarily conducted in sub-
Saharan Africa, have extensively documented a number of
demand-side factors associated with treatment-seeking be-
haviour, including perceptions about the cause and sever-
ity of the illness, quality of care at health facilities,
affordability of treatment, proximity of services to patients,
and positive manner of the providers [21-25].
In Cambodia, the epidemiology of malaria and the spe-
cifics of the treatment environment make the malaria
treatment-seeking process vastly different than that
found in other parts of the globe, particularly the
process in sub-Saharan Africa where most research on
this topic has focused thus far. Cambodian adults – spe-
cifically forest workers – are most afflicted by malaria,
unlike in much of Africa where children under five are
most at risk. As a result, caretaking responsibility rests
with the individual rather than the caregiver of a young
child and access to care is limited, factors which often
guide treatment-seeking decisions in Cambodia. More-
over, while self-treatment of fever at home is common
worldwide, the practice in Cambodia appears to be
much higher than in surveyed sub-Saharan Africa coun-
tries [26]. Cocktail medicines are also more commonly
used in Cambodia and the Southeast Asia region [11,20],
a negligible practice in sub-Saharan Africa [26]. Finally,
malaria treatment practices in Cambodia are compli-
cated by the multiple definitions and cultural under-
standings of “fever”. Cambodia’s main language, Khmer,
uses a variety of terms and definitions for fever such as:
fever with chills (krun janh) or hot body (krun ngak)
known as “malaria fever”; dengue fever (krun chhiem); or
other types of fever or symptoms, such as night fever
(krun yop), high temperature (kdao gadow/kdao kluan)
or sweating (krung loap) [27]. Such variety may further
complicate treatment practices.
To date, only a few unpublished papers provide a de-
scriptive picture of the factors that tend to influence
malaria treatment in Cambodia [28,29]. One of these
studies, a qualitative study from 2004, suggests that a
number of factors influence provider decisions in Cam-
bodia [28]. These include stock outs of test kits and fi-
nancial incentives to sell medicines rather than test
before providing treatment, since a confirmed diagnosis
may diminish medicine sales due to negative test results.
Results also revealed that patients may prefer to spend
money on medicines rather than a test, and may prefer
to self-treat based on their symptoms until they become
more seriously ill [28].
To expand the limited evidence base, this study uses
qualitative methods to explore the demand-side factors
that influence malaria treatment-seeking behaviours and
patient-provider interactions among Cambodian patients.
It aims to shed light on findings from quantitative re-
search studies and offer programmatic recommendations
to increase the uptake of appropriate malaria case man-
agement in Cambodia. It asks three key questions: 1) Why
do people first treat at home and what types of medicines
are used? 2) Why do patients take drug cocktails for mal-
aria and what are their perceptions of these medicines?
and 3) Why do some patients with malaria fever receive a
diagnostic test while others do not? The study findings
aim to provide a more nuanced understanding of the
patient-provider interaction at a health facility or outlet
where malaria treatment is sought, including a patient’s
perception of the provider. Such findings may prove useful
in guiding the design of interventions focused on increas-
ing informed demand for effective malaria case manage-
ment services in Cambodia.
Methods
Researchers employed qualitative in-depth interviews
(IDIs) and focus group discussions (FGDs) to investigate
treatment-seeking behaviours for malaria fever in Cam-
bodia. To understand the complexity of factors related to
diagnosis and treatment-seeking behaviours, two groups
of participants were recruited: adults who reported they
had their malaria fever confirmed through diagnostic
testing and those who reported they did not confirm
their fever with a diagnostic test. FGDs gathered infor-
mation on community level norms and beliefs about
parasitological diagnosis and malaria treatment-seeking
behaviours. IDIs collected data on participants’ individual
experiences when they fell ill with fever, their treatment-
seeking processes and the dynamics of the patient-
provider interaction when seeking care for malaria.
Sampling
A non-probability, purposive sample of the target group
was used to recruit study participants from three
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randomly selected, rural, malaria-endemic districts,
located in the heavily forested areas of Pursat and Kratie
provinces. To find participants, researchers employed a
variety of snowball sampling methods. First, the village
chiefs, health providers, and shop assistants and owners
who sell medicines from various outlets (e.g. pharmacies,
drug stores, etc.) served as key informants to identify
people in the area who recently had fever. Potential par-
ticipants were then asked if they knew of other people in
surrounding villages or forest areas who had experienced
malaria fever (krun janh/krun ngak) in the previous two
weeks.
Researchers used a screening questionnaire to deter-
mine the respondent’s eligibility for inclusion in the
study. They asked whether or not the respondent had
had malaria fever (krun janh or krun ngak) in the previ-
ous two weeks, as opposed to other common types of
fever in Cambodia, such as dengue fever (krun chhiem)
or night fever (krun yop). They also ascertained whether
or not the potential participant’s malaria fever had been
confirmed using a diagnostic test.
Aiming to conduct at least 10 FGDs, with 8-10 partici-
pants each, and 12 IDIs, the research team implemented
12 FGDs and 16 IDIs over a two-week period during the
rainy season in August 2009. Researchers sought to
enrol a similar number of participants into each of the
two sampling groups, those who had received a diagnos-
tic test and those who had not.
Data collection
Teams of four Cambodian social scientists (two women
and two men) hired from the local community con-
ducted the IDIs and FGDs in Kratie and Pursat pro-
vinces. All were trained to correctly use the guides and
study protocols for data management. They held each
in-depth interview in a private space, sometimes at the
home of the individual. FGDs were held in community
centres. Prior to participation, researchers informed
study participants of the study objectives and obtained
verbal consent from all participants. Incentives were
provided in the form of refreshments after participation
as well as a traditional Khmer scarf (kroma). Researchers
made voice recordings of all IDIs and FGDs, with the
consent of participants, and interviewers also took notes
of the content, non-verbal behaviour and setting of the
interaction.
Interview and focus group guides with open-ended
questions addressed key topics related to treatment-
seeking behaviour. Each of these instruments focused on
how participants responded to their fever, where they
sought treatment, why they did or did not receive a diag-
nostic test, what types of treatment they received and
the perceived efficacy of those treatments. While both
the IDI and FGD instruments asked respondents to
describe their most recent episodes of fever, FGD parti-
cipants discussed their recent fever experiences within
the group as a means for helping understand the cultural
and social norms around malaria treatment-seeking be-
haviour. The IDI and FGD guides were translated,
piloted and revised before and during the fieldwork. This
process aimed to improve the clarity of the questions,
assist in assessing topic saturation to guide any needed
changes in the instruments, and allow for any required
increases in the sample size.
Ethics
Ethical approval was obtained for this study from the
Cambodian Ministry of Health Ethical Review Board, 19
July 2009 (#109NECHR).
Data analysis
Recordings from all interviews were transcribed verba-
tim in the original Khmer and then translated into Eng-
lish. On completion, a member of the bilingual research
team read and reviewed each translated English tran-
script, comparing it against the original Khmer version.
The team rectified any discrepancies with the translator
until full agreement between the translated transcript
and original Khmer version was obtained.
Researchers used NVivo qualitative data analysis pack-
age (QSR International Pty 2002) to analyse the data.
Following the principles of grounded theory, the re-
search team coded the transcripts according to common
themes that emerged from the data, letting the data
guide the coding rather than allowing researchers to im-
pose a coding scheme [30]. Given the open nature of the
interview questions, this approach enabled the emer-
gence of unexpected concepts and categories that some-
times had dual meanings, such as “trust in a provider”.
These concepts were inductively generated and coded,
meaning that the same respondent could be coded for
expressing both trust and lack of trust in a provider.
Researchers analysed the frequency with which indivi-
duals reported themes, and to what extent the group
mentioned these themes, for patterns. This procedure
helped clarify which themes consistently emerged across
all groups and which were idiosyncratic [31]. To capture
the main topics emerging from the data, the research
team arranged the descriptive codes into sets of broader
themes. For example, the code, “I always believe provi-
ders will give me the right treatment to cure my fever”
was categorized under the theme, “trust in providers”.
Researchers avoided coding data into categories that
were too small (e.g. “belief that cocktail medicines will
cure fever immediately when working in the forest”), as
such classification can make results difficult to interpret
[32]. Therefore, the team created codes to encapsulate
recurring themes, eventually revisiting the entire dataset
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with the final coding scheme to perform the final
analysis.
To ensure inter-rater reliability in the coding, the re-
search team employed various procedures. First, the
Khmer research staff conducted a paper-based, thematic
analysis on 40% of the IDI and FGD transcripts, using
the final codes that had emerged from the initial analysis
phase. Then, they compared the findings between the
Khmer transcript-based analysis with the initial findings
from the Nvivo analysis. Through this comparison, the
team checked to make sure they had coded the themes
in a consistent manner, without creating new codes in
one type of analysis and not the other. Any discrepancies
were resolved through discussion with the larger team of
coders and the primary analyst until full agreement was
obtained.
To confirm the reliability of the findings, the lead
researchers presented the results to the Khmer research
team upon completion of the analysis. In addition, the
team once again verified any quotes used in the results
summary with the translators.
Results
A total of 60 participants (68% male, 32% female) parti-
cipated in this research study, with a mean age of
32 years. Most respondents had no secondary education:
75% had received primary school education alone while
15% had finished secondary education. Another 10% had
not received any schooling at all. The large majority of
participants were married (85%) and reported working
in forested areas (80%). Per the sampling criteria, all par-
ticipants reported having malaria fever in the previous
two weeks. 27 participants had received a diagnostic test
upon seeking treatment while 33 had not.
It should be noted that the sampling groups – those
who sought diagnostic testing versus those who did not –
did not have any bearing on the results, with the exception
of the expected differences in diagnostic testing. The
emergent themes remained consistent within each group,
so differences in use of self-treatment and cocktail medi-
cines did not appear.
Findings
Types of treatment taken at home
Few participants reported taking immediate steps to
treat their fever. Most waited a few days before seeking
treatment outside the home, either because they were
waiting for symptoms to worsen and/or to ensure the
fever was not the result of a simple cold or flu. They also
waited because they were in the forest, far away from
health centres or outlets where they could purchase
medicines.
Respondents also reported that medicines are expen-
sive and they did not have the money to treat their
fevers. Thus, a common alternative is to treat the fever
at home, using traditional remedies. Many believe the
symptoms can be treated successfully at home, an im-
pression that is also rooted in their perception of the
seriousness of the illness.
Moderator: When you have a hot temperature, where
do you go for treatment?
Respondent 1: First, we treat it at home by ourselves.
We use different medicines to make us feel better, and
which help reduce the fever. The elders say to use a
kind of roof thatching plant, corn and a kind of
aquatic herb that is used as a spice and which keeps
for a year. We boil the core of the corn and use this to
treat the fever.
Respondent 2: But if the fever is not any better after
two or three days, we may go to a hospital or a shop
that sells medicines.
Respondent 3: But if it is serious from the start,
we will go to the hospital right away.
FGD, Pursat Province
Home treatment includes traditional medicines, pri-
marily used to delay, alleviate and/or cure symptoms be-
fore seeking modern alternatives. Most reported drinking
boiled tree roots (e.g. the roots of the lemon tree with al-
cohol or kapok leaves) or taking warm sponge baths with
fragments of ginger, or with guava leaf and the leaf of a
small, sour fruit. They also use other natural remedies, as
described by this forest worker:
Respondent: If we are in the forest, we have nothing
with us. So, we just have trees in the forest such as
“Ampil Brok Phler” and “Merm Krovanh Chruk”.
We just eat them when we do not have medicines.
Moreover, there are “Cheung Kras” grass, and also
coconut stumps which we cut to eat. These are
temporary medicines in the forest until we arrive
home. When we have a serious fever, we can cut the
coconut core into two pieces, tie it with black thread,
insert a nail, and then boil them together to drink
until we get medicine. . . . The [traditional medicines]
can help around 30% or 40%. They can protect us
from running a high temperature. But these
won’t be effective for long, so, three or four days later,
we will start shivering again. However, this mixture
helps us to be able to ride our ox cart home
IDI, 32 year-old, Male Forest Worker, Pursat Province
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While treatment at home is commonplace among
respondents, they generally sought help outside the home
from a qualified provider of health care if the home treat-
ment strategies were perceived as ineffective or failing, or
if symptoms worsened. This source outside the home was
most often the nearest provider of modern medicines.
Sometimes respondents resorted to using modern medi-
cines that they had left over from a previous episode of ill-
ness, even if these medicines were not anti-malarials.
Reasons for taking cocktails
While many respondents rely on traditional medicines
as a primary treatment, the majority of participants
eventually receive some form of modern medication for
their malaria symptoms. A few participants mentioned
brand names without prompting from the interviewer or
FGD facilitator, typically the ACT Malarine (private sec-
tor) or A + M (public sector). However, most respon-
dents did not name the medications they received. The
most common point shared by all respondents about
modern medications focused on cocktails. When they
sought modern treatment, they often received medicines
without formal packaging, presented as cocktails. There-
fore, this section focuses on the study results surround-
ing the perceptions of cocktail medicines, rather than
the perceptions of pre-packaged medicines.
Respondents reported the cocktail medicines are pre-
sented in different forms. Sometimes, the cocktails con-
sist of complete blister packs that have simply been
removed from pre-packaged medicine boxes. In other
cases, providers have cut up the blister packs or removed
the pills from the blisters or tins altogether, placing these
individual pills in the mixture. The providers prepare all
of these formulations in small plastic bags. Instructions
for taking these cocktail medicines direct participants to
take them multiple times a day over the course of several
days, typically using the colour of the pill in the cocktail
(e.g. blue, white, yellow or red) to denote which medi-
cines to take at specific times. Sometimes the instruc-
tions describe a sign or picture imprinted on the pill(s).
Some respondents reported linking the colour of the pill
with the perceived curative agent. For example, they
described the red pills as the pills for energy, while the
light blue pills were “new” treatments for malaria.
Moderator: What sort of medicine were you offered?
Respondent 1: I got pills in a plastic bag. The provider
removed different pills from a blister pack and some
from a big container, and put them into the
plastic bag.
Moderator: The provider removed them from the
blister pack?
Respondent 1: Yes, she did.
Moderator: What about others here? What medicine
did you get?
Respondent 4: I don’t know. The health provider just
prepared a bag for me to take twice per day, morning and
afternoon. I didn’t understand [anything] about those
medicines. I could not recognize them, but I knew they
related to malaria and typhoid. The health providers told
me. They gave me the tablets after I got serum.
Moderator: Did the medicine come with its original
package or cover?
Respondent 4: Some came with its original packaging,
some didn’t. It came in a small plastic bag.
FGD, Pursat Province
Among study participants, the use of cocktails is wide-
spread and is viewed as a “normal” medicine given by pro-
viders. Given the frequency with which respondents
mentioned receiving cocktails, this type of treatment is
deemed a common, standard treatment for all symptoms.
Respondents did not question the efficacy of the cocktail
treatments, regarding them as a “normal” and “common”
type of treatment for malaria from health providers. They
cited trust in the efficacy of these treatments. In addition,
respondents perceive the inclusion of multiple types of pills
in cocktail packages as more effective and less expensive
than a pre-packaged medicine. Many described the need to
not only cure malaria, but also to reduce fever and head-
aches; thus, a combination of pills, targeting multiple symp-
toms, is deemed more effective and more affordable than
purchasing multiple pre-packaged medicines. Respondents
also generally cited trust in their providers and believed that
the provider would only give them an effective medicine:
Interviewer: Do you think these [cocktail] treatments
are effective?
Respondent: Yes, they are good treatments because I
always get better after treating [my illness with them].
And I believe in the medicines because they are given
to me by health providers. They save us. It is the
provider’s job to save us.
Interviewer: How much do you believe in these
treatments?
Respondent: I believe almost 100%.
IDI, 29 year-old, Male Forest Worker, Kratie Province
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Many respondents also discussed how the cocktails are
often saved for later illnesses, or for when they return to
the forest. They also reported stopping the medicine regi-
men prematurely because they felt better, or they needed
the medicines for other family members or their own fu-
ture illnesses, as illustrated by this exchange:
Respondent 2: He [the provider] told me to take it [the
medicine] regularly and on time, and that I have to
finish it even if I am better. And I did follow his
advice.
Moderator: What about others?
Respondent 3: No, I will finish all of it [the medicine].
Respondent 4: I keep one in reserve in case we are sick
next time.
Respondent 5: For me, they prepared four to six bags
for me. And after I finished four bags, my kid became
sick. I knew he had malaria as his toes were cold and
he had a headache. . . and he told me he felt numb.
His face was also numb. So I gave him some
[medicine]. For older people, we need to take only one
tablet, so I cut it into two parts [for my son]. I just give
him half a tablet. After I gave him the medicine, he
got better.
FGD, Pursat Province
Reasons for diagnostic testing
The data suggest that many respondents are not aware
they need a diagnostic blood test to confirm their fever
as malaria. Many also believe they do not need to do a
test because they are able to self-diagnose malaria. Since
many participants claimed they “knew” it was malaria
because the symptoms they had experienced were the
same as those from previous bouts of the illness, they
felt that the additional cost imposed by testing seemed
fruitless. Sometimes this perception was linked to previ-
ous experiences with diagnostic testing; those who had
had prior experience with tests that confirmed fever as
malaria now felt in a better position to recognize when
fever episodes were malaria. Others reported that provi-
ders did not mention the need for a test. Some partici-
pants also noted that they did not know where to get
tested.
Respondent 3: For me, I just went to the shop and got
the medicines. The provider did not tell me to take a
test or anything. He gave me medicines and told me to
take them to cure my fever. So I did. I didn’t know
anything about a test.
Respondent 2: I just got the medicine, too, from the
place near my house. It was given to me for curing my
malaria. I don’t even know where I should find such a
test for malaria.
Respondent 5: Going to have our blood tested once is
enough for us. Next time if we have the same
symptoms, we do not have go get diagnosed again.
Instead, we can just buy medicine from the drugstore.
We know when it is really malaria.
Respondent 8: From my experience, I am used to
having malaria. I observe my son and myself [when we
get sick]. It starts first with yellow eyes. The eyes start
being yellow after we return from the forest. When I
open his eyes, it looks like there is not any red blood
inside them. It’s all a big fever virus. Some called it
like the souls of our ancestors knock us out. It starts
with feeling cold and hot temperatures again and
again. No chills, but after three days, it becomes a
serious fever, and then you become unconscious.
From this, I know it is malaria.
FGD, Kratie Province
For respondents who mentioned seeking treatment
from public or private facilities or clinics, many did not
question the need for a diagnostic test because they
trusted their provider to give them the appropriate treat-
ment. This finding contrasted with responses from those
who obtained treatment from less formal outlets including
village shops or markets; these respondents did not com-
ment on the quality of the provider. Participants perceive
public and private health care providers as knowledgeable
and experienced, as well as able to ascertain what type[s]
of medicine is needed based on their symptoms. Providers
are viewed as being a source of authority in treatment and
diagnosis. Several respondents reported they would accept
any decision handed down by the provider. Often they
were not challenged by the provider to have a test, as illu-
strated by the following discussion:
Respondent: When I got to the health facility, I told
the provider to give me anti-malarial medicine. Also,
the provider did not request or provide blood testing
for me, but only gave me a cocktail.
Interviewer: So what did you tell the provider?
Respondent: When I arrived, I asked him if he could
please give me anti-malarial medicine “for three
times” and he did that for me. In fact, he also has test
equipment [but he didn’t use it on me].
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Interviewer: Why did you ask him to give you anti-
malarial medicine?
Respondent: Because I think my disease is really
malaria. So I just tell him to give me anti-malarials,
which he did for me.
Interviewer: So, he did not ask you anything?
Respondent: He did ask me a few questions, something
like “How did you get malaria?”
IDI, 22 year-old Female, Kratie Province
In contrast, those who received diagnostic testing
noted that blood tests are also seen as part of the treat-
ment plan, as well as something that is prescribed by
providers. The data suggest that receiving a test is often
dependent on where people purchased or obtained med-
icines. Typically, respondents mentioned receiving a test
when they sought treatment from a public health facility
or a private hospital. They also talked about the role of
the provider in this process, citing that receiving a test is
up to the health provider, either public or private, as illu-
strated by the quote below:
Respondent 5. When I arrived, the doctor said that I
have to have a blood test, in order to make it easier to
prescribe the proper treatment. If we do not have a
blood diagnosis, we cannot know what disease it is,
and so we cannot provide proper treatment. After the
blood test, I was informed I have three positive signs of
malaria and I was given A+M.
Respondent 7: First, my feet were cold and I felt my
neck was cold too. So, then I warmed myself by the
fire. After doing this, I was still cold. Then, I went to
sleep without taking any medicine. I started out really
cold until I covered myself with a blanket, but I was
still cold. So, I took two tablets of paracetamol, which
[made me feel] better, although I was sweaty for a
while. Then the chills started again. After that, I was
brought to the hospital.
Moderator: How many days were you sick before you
went to the hospital?
Respondent 7: Three days, then I went to the hospital.
As I did not recover, I went to the hospital for a blood
test. They asked me where I had been. And I said that
I had been in the highland area. Then they asked me
to have a blood test. So, I took it.
FGD, Kratie Province
In other instances, participants said they specifically
sought a diagnostic test in order to understand their ill-
ness, or in order to correctly diagnose the illness and
find the appropriate treatment. In these cases, although
they had familiarity with some malaria symptoms, they
recognized they could not identify the illness on their
own and, therefore, needed a blood test to confirm the
cause of the fever. Others reported taking medicine first
without being tested. When the symptoms did not im-
prove, they decided testing was necessary to find the
“right” treatment. In addition to aiding the identification
of the correct treatment, confirmation of disease also
prevented the risky behaviour of taking an anti-malarial
when it was not needed. Doing so was seen as “danger-
ous”. Participants explained the effects of unnecessary
anti-malarial treatments as “harming the blood vessels”,
“making blood thick”, “weakening the blood” or “shatter-
ing the blood bullet”.
Respondent: Because I felt uneasy inside my body,
I even took traditional medicine as well as the
cocktail which I had bought nearby. I did not recover.
I just spent money on the medicine without
getting good results. That was why I needed the
blood test.
Interviewer: When you got the blood test, did you
request the provider to do it for you or did you just go
there to see what the provider would recommend?”
Respondent: I asked him to do it because I felt strange
in my body. I always had chills and fever and could
not get better by taking the medicine. And I wanted to
know what illness it was, and why I did not get better
even after taking the medicine. So, I asked him to do
the blood test to identify the disease.
Interviewer: Before you did the blood test, what did
you take?
Respondent: Beforehand I just took medicine like
paracetamol and stuff like that for when you have a
fever, and also the thing called Tetra [tetracycline].
Interviewer: Oh, so you didn’t have anti-malarial
medicine?
Respondent: No, that time I did not know I had caught
malaria until I did the blood test. If I had known that
I had caught malaria, I could have chosen the right
medicine
IDI, 34 year-old, Male Forest Worker, Kratie
Province
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Respondents also reported taking a blood test before
going to work in the forest, particularly if they were ex-
periencing malaria symptoms already. They wanted to
ensure the malaria was cured before they travelled long
distances where they would be required to work and
sleep in areas far from any health facilities. They also
reported taking cocktails with them in order to have
medicine on hand in the forest in case they experienced
new symptoms, as this participant demonstrates:
Interviewer: Uncle, did you do the blood test?
Respondent: I did it before going to the forest.
Interviewer: How many days did you do the blood test
before you went to the forest?
Respondent: Three days before I went to the forest.
However, before I went to the forest, I already had had
fever one or two times. That is why I did the blood
test. I thought I could not take cocktails if I go to the
forest again and I do not know what disease I catch.
So I needed to do the blood test to see what illness I
have. Then, I could buy cocktails to take to the forest.
IDI, 45 year-old, Male Forest Worker, Pursat
Province
A number of respondents talked about obtaining mul-
tiple blood tests. They reported that providers could not
recognize the results or needed to double-check the
results at times. Many participants also reported confu-
sion in ascertaining what the results of their tests were.
Sometimes, they were unclear if they had tested positive
for malaria or other illnesses, namely dengue fever or ty-
phoid. In some cases, providers had given respondents
anti-malarials even though their test results were nega-
tive. Others reported getting mixed results from the test:
Respondent 7: First, I had a blood test. The results
showed that I was positive for malaria. I recovered
after I took medicine for malaria. Then I got the chills
again at 8 o’clock. I told my mother that I was not
recovered yet. So, my mother took me to have a blood
test again. The results showed I was positive for
typhoid, not malaria.
FGD, Pursat Province
Discussion
The qualitative results presented in this paper shed light
on the complexity of treatment-seeking behaviour for
malaria among Cambodians, an important issue to
understand in order to effectively implement appropriate
malaria case management in the country. This study pro-
vides a richer understanding of how patient decisions
about treatment choice, the sequence of treatments
(from home-based to facility-based care) and diagnosis
are based on multiple factors. These factors include prior
fevers, treatment experiences, local beliefs about how
fever should be treated, the influence of social networks,
practical considerations such as cost and proximity to
health facilities, and cultural norms. This section dis-
cusses these issues in more detail and suggests interven-
tions that may improve fever case management and
treatment-seeking behaviour among Cambodian patients.
Cambodian cultural practices, norms and beliefs, as
well as practicalities and malaria episode-related factors,
drive decision making about treatment practices. As
demonstrated by other research studies [18,26,33,34],
this study shows that treatment-seeking behaviour for
malaria in Cambodia often starts with self-treatment
prior to any biological diagnosis. When deciding how to
treat oneself for suspected cases of malaria fever, Cam-
bodians who work in forested areas weigh their beliefs in
the effectiveness of these home-based treatments against
their appraisal of available outside treatment options,
such as proximity to health facilities, availability of finan-
cial resources and perceptions of the illness’ severity.
Others have also found that the perceived severity and
duration of illness are influential in the decision to seek
and obtain treatment [21,22,24]. The Cambodians exam-
ined in this study generally seek health care outside the
home when the self-treatment strategies are perceived as
failing, or when the illness is perceived as worsening.
However, even if they do intend to obtain a confirmed
diagnosis and/or obtain appropriate treatment, making
the decision to seek outside care is impacted by trans-
port costs, care costs, the distance to a drug outlet and
knowledge of tests, as confirmed by others [21,22,24].
Treatment-seeking behaviour is also mediated by previ-
ous treatment-seeking behaviour. As evidenced by other
research [35], leftover medicines from previous illness
episodes are reportedly saved and administered when
another family member becomes ill.
Cambodian social norms also encourage the use of
drug cocktails for malaria treatment. Cocktail use is
widespread, a finding demonstrated by this study and
confirmed by other quantitative [11,14,16,17,27] and
qualitative [28] studies in the country. This study’s inter-
views and focus groups showed that cocktails are the
accepted community norm to treat illnesses, suggesting
that this form of medicine is provided for other types of
illness, not just malaria. The perceived affordability of
these cocktails, compared to pre-packaged therapies, is a
strong driver of this community norm. Drug cocktails
are believed to treat multiple symptoms more effectively.
Other evidence has demonstrated similar conclusions,
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noting that cocktails are preferred because they are less
expensive than pre-packaged treatments and patients
can only afford to pay for a certain number of pills at
one time [28].
This study also unveiled the importance of the patient-
provider interaction – and the cultural norms influencing
this interaction – as pivotal in the context of malaria
diagnosis and case management in Cambodia. Because
providers are perceived as providing sound advice and
knowing the best or correct treatments for malaria,
respondents noted that they readily accepted the provi-
der’s treatment and recommendations for malaria care,
including the provision of drug cocktails. They deemed it
unnecessary to question or challenge the provider’s ad-
vice. This norm persisted even in the absence of a sug-
gested diagnosis from the provider. In this sense,
providers are very influential in terms of the decision
making process, a finding supported by other research
[36,37].
Despite this high regard for providers in Cambodian
society, many patients do draw their own conclusions
about the cause of their fever, prompting them to some-
times operate proactively with providers. As discovered
in other research where malaria is described as an indi-
vidual disease identifiable from previous symptom epi-
sodes [38], many respondents in this study associated
their symptoms with previous experiences with the dis-
ease. Consequently, they felt confident engaging in self-
diagnosis and directly asking for malaria treatment from
providers before these practitioners even performed
their own exams. These patients are also hesitant to
spend additional resources on tests when they “know”
they have malaria, a factor that may lead to refusals of
diagnostic testing.
The patient-provider interaction also complicates the
treatment outcome, because the patients may be mis-
guided by providers or are unclear about the recom-
mended treatment or the results of their diagnostic test.
Some study respondents reported being confused about
the results of their malaria test, relating how they were
given anti-malarials even after testing negative for mal-
aria. Others noted that many providers did not recom-
mend or offer a diagnostic test even when they sought
treatment, a finding supported by quantitative provider
and household studies [10,18,39]. In one of these studies,
one third of the surveyed providers believed that malaria
infection could still be confirmed without a blood test,
even though the vast majority (88%) understood that
other diseases can also cause malaria symptoms [39]. In
addition to not recommending diagnostic testing, provi-
ders interacting with participants in this current qualita-
tive study also appeared to deliver inappropriate care or
improperly prescribed medicines. Such findings are sup-
ported by other Cambodian research studies, which
found that a large proportion of prescriptions contain
two or more drugs that could result in adverse drug
reactions, as well as inappropriate practices such as over
prescription of medicines, improper instructions on
treatment duration and the provision of incorrect medi-
cines and/or their dosages [14].
Interpreting findings for programmatic decision making
Given the complexity of treatment-seeking behaviour for
malaria, the findings from this qualitative study may be
useful in shaping communications programs and other
interventions that aim to increase informed demand for
appropriate management of malaria. The practical
recommendations and programmatic considerations that
follow suggest ways to change treatment-seeking behav-
iour as well as improve patient-provider interactions.
Incorporate traditional medicines into behaviour change
communication messages
The use of traditional medicines is deeply rooted in
Cambodian cultural beliefs and norms. Rather than
eschewing these remedies, interventions that promote
diagnostic testing and first-line treatment for confirmed
malaria cases could also consider incorporating local
methods just for symptom relief until proper care can be
found. For example, communication campaigns could
promote the use of specific traditional medicines that
are believed to reduce fever for when the patient first
experiences symptoms and needs relief while travelling
to a facility for a diagnosis and more effective treatment.
Employ simple messages in all BCC materials
Given the complexity of treatment-seeking behaviour in
Cambodia, clear and simple messaging is needed in all
communication materials directed at patients [40,41]. As
proposed in a recent review of socially marketed ACT
and RDT in Cambodia, some suggested messages in-
clude: 1) “If you are going to buy an anti-malarial, only
buy the recommended ACT”; 2) “Before you buy an
anti-malarial, get tested first”; and 3) “If you test nega-
tive, don’t take an anti-malarial” [13]. Existing campaigns
that highlight the dangers of cocktails may also want to
ensure simple messages address the incorrect perception
that cocktails are more effective than pre-packaged med-
icines, particularly for treating multiple symptoms.
Encourage patients to ask for diagnostic testing and
appropriate treatments
Even though Cambodians have a high regard for provi-
ders and often trust their advice without question, this
study and others demonstrate that providers do not al-
ways practice appropriate case management of malaria.
As such, BCC campaigns should encourage patients to
advocate for correct and comprehensive care from their
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providers. Messages could educate patients about the
care they should expect from a health facility, instructing
them to ask for diagnostic testing and proper anti-
malarial treatments. Findings from this study suggest that
Cambodian patients may be open to this messaging ap-
proach, given that they currently feel confident self-
diagnosing malaria, refusing testing and directly asking a
provider for medicine. The intervention goal would be to
convince patients to change their “ask” – from cocktail
medicines without a confirmed diagnosis to a full course
of first-line treatment based on a diagnostic test first.
Focus interventions specifically on provider behaviour and
education
The importance of provider practices and their influence
on the patient are clearly important in determining what
the patient receives, as identified in this study as well as
through other research [30,42-45]. Such influence is of
particular concern when the evidence demonstrates poor
provider practices and lack of adherence to Cambodia’s
case management strategy. A wide range of interven-
tions can lead to key improvements in professional prac-
tice and patient outcomes [42,46,47]. For example,
training of practitioners, provider incentives, recurring
supervisory visits, clear treatment protocols and a regu-
lar supply of equipment are essential for encouraging ap-
propriate malaria diagnosis and treatment [47-49]. Clear
guidelines should also be provided to practitioners on
how to manage patients presenting with malaria-like
symptoms but who are parasite-negative. For designing
and monitoring structured and systematic interventions,
organisations can employ a number of practical tools,
such as provider-based logframes [50], validated behav-
iour change frameworks and provider behaviour change
models [51-54].
Emphasize the inappropriateness of drug cocktails in
provider education
The positive associations and perceptions of cocktail
medicines suggest that behaviour change communica-
tion cannot ignore these formulations and leave them
out of campaign messaging. As health providers are the
ones compiling these cocktail packages, interventions
should target this audience through provider education,
mentoring and supervision, emphasising the distribution
of complete packages of appropriate ACT for confirmed
malaria cases.
Study limitations
As with any qualitative research endeavour, researchers
trade off the generalisability of the findings for richness
and depth in the data. In this study, the non-random
sampling procedure and small sample size reduces the
representativeness of the results. Furthermore, the
snowball procedure used to recruit participants may have
biased the sample, as people are more likely to refer
others who are similar to themselves. In addition, the
results are specific to the population sampled, given the
focus on treatment seeking in just two areas of Cambodia
as well as the inclusion of adults reporting malaria fever
only. Therefore, the results may not be generalisable to
other areas in the country or Southeast Asian region, and
they cannot be extrapolated to treatment decisions for
other types of fever. Additional research is needed to
identify whether these findings are generalisable to a
wider population. A final study limitation is that the tran-
scripts were not back translated into English to identify
discrepancies.
Areas for future research
While this qualitative research increases understanding
of malaria treatment-seeking behaviour in Cambodia
and provides valuable insight into the patient perspec-
tive, there still remains a dearth of evidence on the
supply side (i.e. the providers) of malaria treatment.
Further research is needed on the quality of Cambo-
dian health services, the nature of patient-provider
interactions from the provider perspective, and in par-
ticular, the array of factors that influence and motivate
providers’ testing and dispensing behaviours with
regards to malaria. Provider research is also needed in
the area of malaria drug cocktails, to understand how
attitudes and practices may be changing as well as to
pinpoint the types of interventions that may prove suc-
cessful in combating the widespread misuse of these
medicine combinations. Additional research on cock-
tails should also determine what medicines are found
in these mixtures (e.g. anti-malarials, antibiotics) to
better understand how these cocktails may be used to
treat illnesses other than malaria, a topic currently
being investigated by a number of research collabora-
tors [55]. Finally, malaria treatment interventions will
benefit from research studies focused on patient costs,
access issues and provider financial incentives. While
previous research has documented the availability,
price, market share and use of anti-malarials in Cam-
bodia [15,17,18], no known studies have linked demand
and supply side data to determine Cambodians’ ability
to access these first-line treatments.
Conclusion
Although substantial gains have been made in malaria
treatment and service delivery in Cambodia, there is still
room for improvement in terms of appropriate case
management for suspected malaria cases – namely,
higher levels of diagnostic testing prior to treatment and
a shift away from the provision of drug cocktails for the
disease. Given the pressing issue of artemisinin
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resistance in the area, including multidrug resistance,
encouraging providers to adopt both behaviours is
essential.
This study – one of the first of its kind in Cambodia
and in Southeast Asia – examines the demand-side fac-
tors that influence patients’ behaviour in treatment
choice, the sequence of treatment taken and provider
interactions, including the acceptance and demand for
testing and first-line anti-malarials. Effective intervention
programmes will leverage these demand-side factors to
promote prompt treatment-seeking behaviour for sus-
pected malaria through channels delivering appropriate
case management. On the supply side, given the pivotal
role providers play in ensuring the delivery of appropri-
ate care for malaria and their influence in shaping pa-
tient treatment-seeking behaviour, interventions
designed to improve provider knowledge and the prac-
tice of appropriate case management are also needed.
Future malaria intervention programmes and research
that considers both the patient’s and the provider’s side
of the interaction will strengthen appropriate malaria
care in Cambodia and, ultimately, lead to reductions in
the malaria disease burden.
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